Useful Management Information

  • Many drugs affect renin and aldosterone secretion and may affect interpretation of aldosterone: renin ratio - it is best to check the aldosterone : renin ratio prior to commencing anti-hypertensive treatment if possible in people with young onset of hypertestion
  • Hypertension (General Medicine) CPC

Minimum Referral Criteria

Does your patient meet the minimum referral criteria?
Category 1 (appointment within 30 calendar days)
  • Confirmed phaeochromocytoma or suspected with uncontrolled hypertension
  • Patients with severe persistent hypertension (SBP >180mmHg but below 220 mmHg) without concerning features:
    • headache
    • confusion
    • blurred vision
    • retinal haemorrhage
    • reduced level of consciousness
    • seizures
    • proteinuria
    • papilloedema
    • signs of heart failure
    • chest pain
    • acute kidney injury
  • Hypertension that persists after trial of oral medication as described by the Heart Foundation Hypertension Guideline
  • Confirmed or suspected Cushing's Syndrome
  • Confirmed or suspected Primary Hyperaldosteronism with potassium <3mmol/L
Category 2 (appointment within 90 calendar days)
  • Primary hyperaldosteronism (Conn’s syndrome) with potassium ≥3 mmol/L
  • Patients suspected of having any other secondary endocrine cause for hypertension
  • Patients with hypertension (but ≤180/100) in whom renal artery stenosis is suspected (consider referral to vascular if available)
  • Patients with resistant hypertension (but ≤180/100) despite receiving 3 or more antihypertensive agents in optimal dose and no underlying ischaemic heart disease, cardiomyopathy, or chronic kidney disease
  • Patients with hypertension (but ≤180/100) who have intolerances to multiple antihypertensive agents
Category 3 (appointment within 365 calendar days)
  • If the patient does not meet the criteria for referral but the referring practitioner believes the patient requires specialist review, a clinical override may be requested:
    • Please explain why (e.g. warning signs or symptoms, clinical modifiers, uncertain about diagnosis, etc.)
  • Please note that your referral may not be accepted or may be redirected to another service.

Essential Referral Information

  • Renin, aldosterone
  • Plasma free metadrenaline and normetadrenaline
  • 1mg dexamethasone suppression test and/or 24hr urinary free cortisol
  • Renal duplex report (only if renal artery stenosis suspected)
  • Details of all treatments offered and efficacy
  • BP (BP measurements on both arms preferable)
  • Relevant previous medical history and co-morbidities
  • FBC, ELFTs, eGFR, fasting lipids
  • Urinalysis
  • Urinary protein estimation or albumin : creatinine ratio
  • CXR report
  • ECG
  • If a specific test result cannot be obtained due to access, financial, religious, cultural or consent reasons a clinical override may be requested. This reason must be clearly articulated in the body of the referral.

Additional Referral Information

  • 24 hour ambulatory Blood Pressure monitoring
Last updated 1 December 2024

Send Referrals To

Smart Referrals

Preferred Method
About Smart Referrals

Secure Web Transfer

Send to: Gold Coast Health Service District

Internal Referrals

Diabetes/Endocrinology (E-Blueslips)

Fax

(07) 5687 4497

Post

Booking and Referral Centre
Gold Coast University Hospital
1 Hospital Boulevard
Southport QLD 4215

Enquiries

1300 559 083

Related HealthPathways

No directly related pathways found

Service Availability

Dr Katherine Griffin
Medical Director Diabetes and Endocrinology

Facilities

Gold Coast University Hospital
Robina Hospital

If you would like to send a named referral, please address it to the specialist listed above, who will allocate a suitably qualified specialist to see the patient. Alternatively, you can view a full list of our specialists.

Gold Coast Health - For Clinicians
© The State of Queensland 1995-2021 | Queensland Government
Queensland Government acknowledges the Traditional Owners of the land and pays respect to Elders past, present and future.